DOCS vs GSK · P/E 21, rev $570.4M vs P/E 13, $103.31B cap
Doximity Inc (DOCS) versus GlaxoSmithKline PLC ADR (GSK) — a side-by-side from cached financials, not a winner call.
Doximity Inc (DOCS) is a health information services company listed on US.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Latest reported DOCS revenue for 2025-03-31 was $570.4M. Net income was $223.2M. Revenue was up 20.0% from 2024-03-31 to 2025-03-31. DOCS currently screens at market cap $3.77B and trailing P/E 21.0.
GSK does not have a complete income-statement cache yet.
DOCS currently screens at market cap $3.77B and trailing P/E 21.0. GSK currently screens at market cap $103.31B and trailing P/E 13.5.
Not investment advice. Open the DOCS and GSK stock pages for the full models.
Not investment advice.